Publika - Scientific publications from Oslo University Hospital

RSS feed RSS

Publications by Vegard Tjomsland

15 publications found

Original articles

Morin E, Sjöberg E, Tjomsland V, Testini C, Lindskog C, Franklin O, Sund M, Öhlund D, Kiflemariam S, Sjöblom T, Claesson-Welsh L (2018)
VEGF receptor-2/neuropilin 1 trans-complex formation between endothelial and tumor cells is an independent predictor of pancreatic cancer survival
J Pathol, 246 (3), 311-322
DOI 10.1002/path.5141, PubMed 30027561

Tjomsland V, Aasrum M, Christoffersen T, Gladhaug IP (2017)
Functional heterogeneity in tumor-derived human pancreatic stellate cells: Differential expression of HGF and implications for mitogenic signaling and migration in pancreatic cancer cells
Oncotarget, 8 (42), 71672-71684
DOI 10.18632/oncotarget.17800, PubMed 29069737

Tjomsland V, Sandnes D, Pomianowska E, Cizmovic ST, Aasrum M, Brusevold IJ, Christoffersen T, Gladhaug IP (2016)
The TGFβ-SMAD3 pathway inhibits IL-1α induced interactions between human pancreatic stellate cells and pancreatic carcinoma cells and restricts cancer cell migration
J Exp Clin Cancer Res, 35 (1), 122
DOI 10.1186/s13046-016-0400-5, PubMed 27473228

Tjomsland V, Pomianowska E, Aasrum M, Sandnes D, Verbeke CS, Gladhaug IP (2016)
Profile of MMP and TIMP Expression in Human Pancreatic Stellate Cells: Regulation by IL-1α and TGFβ and Implications for Migration of Pancreatic Cancer Cells
Neoplasia, 18 (7), 447-56
DOI 10.1016/j.neo.2016.06.003, PubMed 27435927

Kuninty PR, Bojmar L, Tjomsland V, Larsson M, Storm G, Östman A, Sandström P, Prakash J (2016)
MicroRNA-199a and -214 as potential therapeutic targets in pancreatic stellate cells in pancreatic tumor
Oncotarget, 7 (13), 16396-408
DOI 10.18632/oncotarget.7651, PubMed 26918939

Aasrum M, Tjomsland V, Thoresen GH, De Angelis PM, Christoffersen T, Brusevold IJ (2015)
PI3K is required for both basal and LPA-induced DNA synthesis in oral carcinoma cells
J Oral Pathol Med, 45 (6), 425-32
DOI 10.1111/jop.12384, PubMed 26602326

Pomianowska E, Sandnes D, Grzyb K, Schjølberg AR, Aasrum M, Tveteraas IH, Tjomsland V, Christoffersen T, Gladhaug IP (2014)
Inhibitory effects of prostaglandin E2 on collagen synthesis and cell proliferation in human stellate cells from pancreatic head adenocarcinoma
BMC Cancer, 14, 413
DOI 10.1186/1471-2407-14-413, PubMed 24912820

Tjomsland V, Bojmar L, Sandström P, Bratthäll C, Messmer D, Spångeus A, Larsson M (2013)
IL-1α expression in pancreatic ductal adenocarcinoma affects the tumor cell migration and is regulated by the p38MAPK signaling pathway
PLoS One, 8 (8), e70874
DOI 10.1371/journal.pone.0070874, PubMed 23951028

Tjomsland V, Spångeus A, Välilä J, Sandström P, Borch K, Druid H, Falkmer S, Falkmer U, Messmer D, Larsson M (2011)
Interleukin 1α sustains the expression of inflammatory factors in human pancreatic cancer microenvironment by targeting cancer-associated fibroblasts
Neoplasia, 13 (8), 664-75
DOI 10.1593/neo.11332, PubMed 21847358

Tjomsland V, Niklasson L, Sandström P, Borch K, Druid H, Bratthäll C, Messmer D, Larsson M, Spångeus A (2011)
The desmoplastic stroma plays an essential role in the accumulation and modulation of infiltrated immune cells in pancreatic adenocarcinoma
Clin Dev Immunol, 2011, 212810
DOI 10.1155/2011/212810, PubMed 22190968

Tjomsland V, Spångeus A, Sandström P, Borch K, Messmer D, Larsson M (2010)
Semi mature blood dendritic cells exist in patients with ductal pancreatic adenocarcinoma owing to inflammatory factors released from the tumor
PLoS One, 5 (10), e13441
DOI 10.1371/journal.pone.0013441, PubMed 20976171

Tjomsland V, Sandström P, Spångeus A, Messmer D, Emilsson J, Falkmer U, Falkmer S, Magnusson KE, Borch K, Larsson M (2010)
Pancreatic adenocarcinoma exerts systemic effects on the peripheral blood myeloid and plasmacytoid dendritic cells: an indicator of disease severity?
BMC Cancer, 10, 87
DOI 10.1186/1471-2407-10-87, PubMed 20214814

El-Salhy M, Hilding L, Royson H, Tjomsland V (2005)
Comparison between triple therapy with octreotide, galanin and serotonin vs. irinotecan or oxaliplatin in combination with 5-fluorouracil/leukovorin in human colon cancer
Int J Oncol, 27 (3), 687-91
PubMed 16077917

El-Salhy M, Tjomsland V, Theodorsson E (2005)
Effects of triple treatment with octreotide, galanin and serotonin on a human pancreas cancer cell line in xenografts
Histol Histopathol, 20 (3), 745-52
DOI 10.14670/HH-20.745, PubMed 15944923

Tjomsland V, El-Salhy M (2005)
Effects of single, double or triple combinations of octreotide, galanin and serotonin on a human pancreatic cancer cell line
Histol Histopathol, 20 (2), 537-41
DOI 10.14670/HH-20.537, PubMed 15736059

0.11s